Flavia Veera Castelino, M.D.
Rheumatology Physician · Boston, MA
Flavia Veera Castelino, M.D. is a rheumatology physician with a practice address in Boston, Massachusetts, and NPI 1962611301, issued on May 22, 2007. Check the license (Massachusetts 231346, as entered in NPPES) on the Massachusetts Board of Registration in Medicine; the Medicare figures below come from public CMS files.
- Name
- Flavia Veera Castelino
- Credential
- M.D.
- Primary taxonomy
- Rheumatology Physician 207RR0500X
- License number
- 231346 MA
Self-reported in NPPES; status is on the state search - Practice location
- 55 Fruit St Yawkey 2C, Boston, MA 02114
- Phone
- (617) 726-7938
- Enumerated
- May 22, 2007
- Record last updated
- Feb 18, 2011 (not updated in 15 years: call before relying on the address or phone)
- Medicare enrollment
- Enrolled (PECOS I20090616000214); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest rheumatology physician records → All 343 in Massachusetts → Look up another NPI →
Verify Flavia Veera Castelino in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMassachusetts Board of Registration in Medicine
Search for license 231346Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
43% fewer Medicare Part D claims than the average rheumatology physician in 2024
1,136 Medicare Part D claims for 220 beneficiaries, against an average of 1,978 among the 6,301 providers of this specialty who prescribed in Part D.
Most prescribed
- Methotrexate203 claims
- Prednisone142 claims
- Humira(Cf) Pen124 claims
- Mycophenolate Mofetil86 claims
- Hydroxychloroquine Sulfate65 claims
- Allopurinol52 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $14,619.61
7 payments; by number, the most common kind was food and beverage; the largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. The 4,486 providers of this specialty with any payment received $8,538.33 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Massachusetts General Physicians Organization IncBoston, MA
- The General Hospital CorporationWaltham, MA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Flavia Veera Castelino among 343 rheumatology physician records in Massachusetts
Flavia Veera Castelino, M.D. is one of 343 rheumatology physician records with a practice address in Massachusetts. 73% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 55% of them.
- NPI issued2007 · 55% of these records are older, 38% newer
- In a Medicare fileYes · 73% of these records are
- In the CMS Doctors and Clinicians fileYes · 62% of these records are
- Graduated2004 · median 2004 among the 212 with a school on file
- Record last updated2011 · 62% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RR0500X and a Massachusetts practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Rheumatology Physician providers in Massachusetts
There are 343 rheumatology physician records in Massachusetts.
All 343 in Massachusetts → Every provider in Boston → Rheumatology Physician nationwide →
The 8 rheumatology physician records with the nearest ZIP codes
- Syed Ahmed, M.D.Boston, MA 021141407829948
- Sheila Arvikar, M.D.Boston, MA 021141881721249
- Donald Bloch, MDBoston, MA 021141609857739
- Kurt Bloch, MDBoston, MA 021141326020652
- Marcy Bolster, MDBoston, MA 021141154439198
- Robert Friday, MD PHDBoston, MA 021141053393074
- Nancy Kim, M.D.Boston, MA 021141669447090
- Minna Kohler, M.D.Boston, MA 021141518924711
Common questions
What is Flavia Veera Castelino, M.D.'s NPI number?
Flavia Veera Castelino, M.D.'s National Provider Identifier (NPI) is 1962611301, issued on May 22, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Flavia Veera Castelino, M.D. located?
The NPPES record lists a practice address at 55 Fruit St Yawkey 2C, Boston, MA, 02114. Phone: (617) 726-7938. Providers update this record themselves, so call before visiting.
How can I verify Flavia Veera Castelino, M.D.'s license?
NPPES lists Massachusetts license number 231346, as entered by the provider. Search the Massachusetts Board of Registration in Medicine at https://findmydoctor.mass.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Flavia Veera Castelino, M.D. prescribe under Medicare Part D?
In 2024, Flavia Veera Castelino, M.D. had 1,136 Medicare Part D claims for 220 beneficiaries; the average among rheumatology physician prescribers was 1,978. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.